• Technology
    • Resources
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
    • Corporate Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact IR
  • Blog
  • Contact
Nautilus Biotechnology
  • Technology
    • Resources
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • IR Resources
  • Blog
  • Contact

What are protein biomarkers?

April 18, 2023
Gracie Murphy
LinkedIn

Biomarkers are broadly defined as physiological and biological signs that can be measured to assess both normal and abnormal biological processes. This term encompasses a wide spectrum of medical signs, ranging from blood pressure and body temperature to genetic mutations and specific proteins. Doctors rely on biomarkers to guide diagnoses and prescribe a treatment plan, yet existing biomarkers only make up a fraction of possible indicators of disease. Underneath the recognizable signs of disease, there is a plethora of molecular interactions. Protein biomarkers can play a role both in the mechanisms underlying disease and as a way of signaling the presence of disease. Identifying these biomarkers weeks, months, or even years before physical symptoms manifest has become a valuable area of research for diagnostic and treatment purposes. This post explores the immense potential of biomarkers in healthcare and how the Nautilus Proteome Analysis Platform is designed to enable unprecedented progress within this field.

 

Graphic featuring a definition of protein biomarkers. Biomarkers are proteins whose presence, absence, or modification indicate normal or abnormal biological processes. On the left side of this graphic there is a blue human body with a few blue dots inside it representing protein biomarkers of good health. On the right there is a red body where one of the blue biomarker dots has turned orange indicating ill health.

The potential for biomarkers in clinical research and diagnostics

Biomarkers already have an established role in the development of therapeutics and diagnostics. Acute inflammation can be detected by measuring levels of C reactive protein in the blood, and Carcinoembryonic Antigen (CEA) can indicate the presence of colon cancer in some patients. These proteins help doctors narrow in on the cause and progression of disease, while also evaluating response to treatment.

  

Looking more closely at the molecular level helps alert doctors to the presence of disease before recognizable symptoms emerge while also reducing ambiguity surrounding underlying causes of certain symptoms. In diseases such as cancer where early treatment is crucial, there is a major focus on identifying biomarkers that signal the presence of malignant cells before they congregate into a noticeable lump or travel to new tissue. For several diseases, like Amyotrophic Lateral Sclerosis (ALS), with no test or procedure to provide a definitive diagnosis and symptoms mimicking other neurodegenerative diseases, biomarkers have the potential to finally provide patients with answers.

 

Beyond diagnostics, understanding the molecular workings behind the progression and symptoms of disease uncovers a variety of pathways and molecules that may be attractive therapeutic targets. Biomarkers can also be used to understand why some individuals respond to certain therapies better than others, allowing for the creation of more effective treatment plans.

 

If biomarkers are a key to early detection, diagnosis, and treatment, then why haven’t we uncovered a biomarker for every human disease? It is certainly not for lack of effort.

 

Current biomarker discovery methods and challenges

To discover biomarkers, researchers often compare a healthy control group to a disease group, digging into the distinct differences in DNA, RNA, metabolites, and proteins. For protein biomarkers, this phase is characterized by the identification and quantification of as many proteins as possible to propose a range of biomarker candidates. Protein biomarkers have predominantly been investigated through mass spectrometry, a technique utilized for the identification and quantification of proteins. The possible biomarkers are then passed through a gauntlet of analytical and clinical validation to ensure sensitivity, reproducibility, and association with the endpoint of interest (see Fang-Shu Ou et al 2021 for a thorough overview of the process).

 

Several challenges face the current field of biomarker discovery. While mass spectrometry has been a powerful proteomics tool for many years, it has difficulty detecting low abundance proteins in a sample. In blood for instance, 97% of the plasma protein mass is made up of the 20 most abundant proteins, often drowning out low abundance proteins in mass spectrometry analysis. These low abundance proteins and their modifications make up a valuable source of potential biomarkers that are beyond reach.

 

Mass spectrometry’s high degree of difficulty also makes the proteome analysis required for biomarker discovery an arduous task that still struggles to reveal the whole picture. Because of this, the biomarker discovery phase often compares a limited number of samples that may not be truly representative (see Nakayasu et al 2021 for a review of mass spectrometry in biomarker discovery).

 

To advance biomarker discovery, we first must ensure that we have the methods to capture all the proteins and proteoforms that may be involved with disease.

 

Revolutionizing biomarker discovery with Nautilus’s Proteome Analysis Platform

The Nautilus Proteome Analysis Platform may be the exact tool needed to ignite breakthroughs in biomarker discovery. The platform is designed to identify and quantify proteins and proteoforms in a mixed sample at the single-molecule level, transcending prior limits to sensitivity and proteome coverage.

 

Rather than hoping a useful biomarker is detected in the fragments of the proteome analyzed, the Nautilus platform is designed to identify and quantify more than 95% of all proteins in the proteome, uncovering biomarker candidates that may have been missed using traditional methods. In addition, we’re designing a simple workflow from sample prep to data analysis that may enable more samples to be examined. We hope this will create robust datasets and more comprehensive comparisons between control and disease cohorts. This process will likely lead to more significant biomarkers being discovered, improving diagnostic and therapeutic strategies.

 

We’re working to drive a proteomics revolution — reshaping how we research, detect, and treat human disease. Biomarker discovery is just one of the many ways in which technological breakthroughs in proteomics can benefit human health. Explore some of the other applications of proteomics — spanning from precision medicine to basic research — in our white paper series.

Browse by topic

  • Nautilus in the News
  • Events
  • Research and Collaborations
  • Applications of Proteomics
  • Nautilus and our Platform
  • Proteomics
  • Life at Nautilus
  • Industry Interviews
SUBSCRIBE
Back To Blog

Nautilus Biotechnology

 

Corporate Headquarters
2701 Eastlake Avenue East
Seattle, WA 98102

 

Research Headquarters
835 Industrial Road, Suite 200
San Carlos, CA 94070

 

     

+1 (206) 333-2001

© 2023 Nautilus Biotechnology Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

We use cookies in order to continually improve your experience on our website. By clicking “Accept cookies” or clicking on any content on our site, you are consenting to our use of cookies as described in our Privacy Policy. You can opt-out if you wish. Accept Reject All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT